pdCSM-GPCR: predicting potent GPCR ligands with graph-based signatures. (2021)
Attributed to:
Newton001 Understanding Antimicrobial Resistance Mutations in Tuberculosis: Towards Personalised Treatment to Combat Multi-drug Resistance
funded by
Newton Fund
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/bioadv/vbab031
PubMed Identifier: 34901870
Publication URI: http://europepmc.org/abstract/MED/34901870
Type: Journal Article/Review
Volume: 1
Parent Publication: Bioinformatics advances
Issue: 1
ISSN: 2635-0041